Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05956340 · ClinicalTrials.gov registry record · NA
A Study of Spoken Language in Mania
A NA study of Bipolar I Disorder and Manic Episode, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT05956340 is a NA study of Bipolar I Disorder and Manic Episode that has completed, run by Mayo Clinic. The registered enrollment target is 17 participants, below the 329-participant average among 26 other Bipolar I Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05956340, a NA study of Bipolar I Disorder and Manic Episode, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to find if there are changes with voice and speech during episodes of mania.
Conditions Studied
Interventions
- BEHAVIORAL Research interview
Study Locations (1)
Minnesota
- Mayo Clinic Minnesota - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-04-27 |
| Est. Completion | 2024-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05956340
The ClinicalTrials.gov registry entry for NCT05956340 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 329-participant average among 26 other Bipolar I Disorder trials with a reported enrollment target (95% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bipolar I Disorder appearing as the primary indexed condition, and to 1 intervention - of which Research interview is the first listed.
NCT05956340 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05956340 about?
NCT05956340 is a clinical study titled "A Study of Spoken Language in Mania". This research is being done to find if there are changes with voice and speech during episodes of mania.
What is the current status of trial NCT05956340?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2023-04-27. Estimated completion is 2024-09-09.
What conditions does trial NCT05956340 study?
This clinical trial studies the following conditions: Bipolar I Disorder, Manic Episode.
What interventions are being tested in trial NCT05956340?
The interventions under investigation include: Research interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT05956340?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05956340 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar I Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
RECRUITING · NA
-
Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression
ACTIVE NOT RECRUITING · NA
-
LiveWell: A Mobile Intervention for Bipolar Disorder
COMPLETED · NA
-
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
RECRUITING · Phase 2
-
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RECRUITING · Phase 3
-
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.